Molecule intelOpportunity: ModerateEssentialCrowded market

Trimethoprim

197 brands · 113 companies · product forms

ATC: J01EA01 1 DRAP alert

Opportunity snapshot

Launch attractiveness
49
Market saturation
100
Price room
100
Regulatory risk
50
197
brands
113
companies
Rs 428.63
median price
95
price points
46.25x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 4%

Price room

Across observed sources and strengths
CheapestRs 20.96
MedianRs 428.63
Most expensiveRs 969.34
Spread46.25×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 46.25x across 95 trusted points (Rs 20.96-969.34). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Trimethoprim — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2022-02-08
Drug Product Recalls: Cozol Suspension (Batch # E206) By M/S. Alkemy Pharmaceutical Labora

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

113 canonical companies and 197 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 46.25x across 95 trusted points (Rs 20.96-969.34). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2022-02-08 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.